The trademark bioNSAID certified www.bionsaid.com was filed by Sinteryx Pharma BV, a corporation established under the laws of the Kingdom of Belgium (the "Applicant"). The application was published for oppositions on July 26, 2020, and received one opposition filed on October 25, 2020 by P&G Health Germany GmbH on Likelihood of confusion. the opponent was represented by BAKKER & VERKUIJL B.V. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued October 25, 2020
The application was filed in Dutch, and Dutch was also language of all opposition proceedings (English was selected as the second language).